Low-dose nitric oxide therapy for persistent pulmonary hypertension: 1-year follow-up (Q47876950)

6 February 2018

title

Low-dose nitric oxide therapy for persistent pulmonary hypertension: 1-year follow-up (English)

1 reference

6 February 2018

main subject

pulmonary hypertension

1 reference

8

1 reference

6 February 2018

author name string

Reese H Clark

1

1 reference

6 February 2018

Jeryl L Huckaby

2

1 reference

6 February 2018

Thomas J Kueser

3

1 reference

6 February 2018

Marshall W Walker

4

1 reference

6 February 2018

W Michael Southgate

5

1 reference

6 February 2018

Jose A Perez

6

1 reference

6 February 2018

Beverly J Roy

7

1 reference

6 February 2018

Clinical Inhaled Nitric Oxide Research Group

9

1 reference

6 February 2018

publication date

1 June 2003

1 reference

6 February 2018

published in

Journal of Perinatology

1 reference

6 February 2018

volume

23

1 reference

6 February 2018

issue

4

1 reference

6 February 2018

page(s)

300-303

1 reference

6 February 2018

https://scigraph.springernature.com/pub.10.1038/sj.jp.7210908

exact match

0 references

cites work

Recent developments in inhaled nitric oxide therapy of the newborn

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7210908

Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. The Inhaled Nitric Oxide Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7210908

Neurodevelopmental and medical outcomes of persistent pulmonary hypertension in term newborns treated with nitric oxide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7210908

Outcome in term infants treated with inhaled nitric oxide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7210908

Predictors of early childhood outcome in candidates for extracorporeal membrane oxygenation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7210908

Severe respiratory failure in neonates: mortality and morbidity rates and neurodevelopmental outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7210908

UK collaborative randomised trial of neonatal extracorporeal membrane oxygenation: follow-up to age 4 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7210908

Low-Dose Nitric Oxide Therapy for Persistent Pulmonary Hypertension of the Newborn

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7210908

7 January 2021

Inhaled nitric oxide in term and near-term infants: neurodevelopmental follow-up of the neonatal inhaled nitric oxide study group (NINOS)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7210908

7 January 2021

Inhaled nitric oxide for the early treatment of persistent pulmonary hypertension of the term newborn: a randomized, double-masked, placebo-controlled, dose-response, multicenter study. The I-NO/PPHN Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7210908

7 January 2021

Randomized, multicenter trial of inhaled nitric oxide and high-frequency oscillatory ventilation in severe, persistent pulmonary hypertension of the newborn

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7210908

7 January 2021

Frequency of chronic lung disease in infants with severe respiratory failure treated with high-frequency ventilation and/or extracorporeal membrane oxygenation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JP.7210908

7 January 2021

Identifiers

DOI

10.1038/SJ.JP.7210908

1 reference

6 February 2018

Dimensions Publication ID

0 references

1 reference

6 February 2018